Apigenin: Clinical Trials

6 trials of Apigenin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 5 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 4, Unknown 1
Phase 11Completed 1
Phase 21Completed 1

Follow Apigenin: new trials by email Literature Review of Apigenin trials Research Report on Apigenin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Supplement Combination on Stress and Sleep
All Active Supplement Combinations (Ashwagandha, Rhodiola rosea, magnesium threonate, L-theanine, and apigenin)), AM Active Supplement Combination (Ashwagandha and Rhodiola rosea), PM Active Supplement Combination (Magnesium threonate, L-theanine, and apigenin) - Healthy
Not applicableCompletedUniversity of South Carolina1152025-02-152026-02-11
Cryopreservation Medium With Apigenin on Post-thaw Human Sperm
Apigenin - Healthy
Not applicableCompletedChulalongkorn University572024-10-282025-03-18
Improvement of Organ Function by Apigenin in Elderly Patients With Sepsis
apigenin, sterilized water - Sepsis, Septic Shock
Phase 1 / Phase 2CompletedZhujiang Hospital202023-09-012024-03-13
Role of Saffron and Chamomile in the Management of Parkinson's Disease
conventional therapy, Saffron and Chamomile, Crocin and Apigenin - Parkinson Disease, Neurodegenerative Diseases
Not applicableUnknownJinnah Postgraduate Medical Centre1202022-07-052023-01-25
Clinical Trial to Evaluate the Reduction of Cardiovascular Risk
Apigenin, luteonin, grapefruit extract and citrolive, maltodextrina - Cholesterol
Not applicableCompletedUniversidad Católica San Antonio de Murcia1002016-10-012019-10-03
Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides
Chamomile Tea, Parsley based drink, Parsley Yogurt - Healthy
Not applicableCompletedUniversity of California, Davis172015-01-202019-05-23

Conditions studied

Neurodegenerative Diseases (1)  ·  Parkinson Disease (1)  ·  Sepsis (1)  ·  Shock, Septic (1)

Sponsors

Chulalongkorn University (1)  ·  Jinnah Postgraduate Medical Centre (1)  ·  Universidad Católica San Antonio de Murcia (1)  ·  University of California, Davis (1)  ·  University of South Carolina (1)  ·  Zhujiang Hospital (1)

Countries

United States (2)  ·  China (1)  ·  Pakistan (1)  ·  Spain (1)  ·  Thailand (1)

Top investigators

Carl L Keen, PhD (1)  ·  Fizzah Ali, MBBS,MPhil (1)  ·  Javier I Ottaviani, PhD (1)  ·  Punyawee Utaipatanacheep (1)  ·  Zhanguo Liu, M.D.PhD (1)

Results publications

PMID 11870124, PMID 14501696, PMID 18491957, PMID 18704674, PMID 19834132, PMID 20306120, PMID 22194740, PMID 22591546, PMID 24259508, PMID 24614817, PMID 24904963, PMID 25285571, PMID 25382909, PMID 25945243, PMID 26688188, PMID 27126062, PMID 27342905, PMID 27351024, PMID 27514990, PMID 27706421, PMID 28255865, PMID 28389404, PMID 28951838, PMID 28963002, PMID 29147836, PMID 29708294, PMID 30143329, PMID 30159851, PMID 30453816, PMID 30569652, PMID 30694450, PMID 31111370, PMID 31402476, PMID 31967363, PMID 33884167, PMID 34067222, PMID 34067384, PMID 34224829, PMID 35071326, PMID 35274200, PMID 35335140, PMID 35452808, PMID 36054457, PMID 36171267, PMID 36197144, PMID 36321244, PMID 37276727, PMID 38176575, PMID 38261086, PMID 38402367